Accessibility Menu
Black Diamond Therapeutics Stock Quote

Black Diamond Therapeutics (NASDAQ: BDTX)

$3.86
(2.7%)
+0.10
Price as of October 23, 2025, 11:50 a.m. ET

KEY DATA POINTS

Current Price
$3.86
Daily Change
(2.7%) +$0.10
Day's Range
$3.74 - $3.92
Previous Close
$3.76
Open
$3.75
Beta
1.44
Volume
237,763
Average Volume
940,329
Market Cap
214.1M
Market Cap / Employee
$3.76M
52wk Range
$1.2 - $4.45
Revenue
-
Gross Margin
1.00%
Dividend Yield
N/A
EPS
$0.24
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Black Diamond Therapeutics Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
BDTX+13.6%-88.2%-34.78%-90%
S&P+14.5%+93.32%+14.09%+104%

Black Diamond Therapeutics Company Info

Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$0.00M0.0%
Gross Profit-$0.09M0.0%
Gross Margin99.88%0.0%
Market Cap$141.02M-46.2%
Market Cap / Employee$5.88M0.0%
Employees24-55.6%
Net Income-$10.56M47.0%
EBITDA-$13.33M39.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$29.99M-8.6%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$16.97M-17.3%
Short Term Debt$3.78M16.2%

Ratios

Q2 2025YOY Change
Return On Assets9.13%68.8%
Return On Invested Capital-53.93%-9.1%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$9.16M0.0%
Operating Free Cash Flow-$9.16M37.8%

Valuation

MetricQ1 2025Q2 2025YoY Change
Price to Earnings25.1210.47-
Price to Book2.211.241.050.99-57.68%
Price to Sales1.282.01-
Price to Tangible Book Value2.211.241.050.99-57.68%
Enterprise Value to EBITDA-8.65-2.46-0.76-1.41-80.31%
Return on Equity-63.1%-69.7%4.1%11.9%-114.22%
Total Debt$23.00M$22.19M$21.59M$20.75M-12.74%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.